2016-03-15T00:00:00.000-04:00
licensing transactions,0.457727
pharmaceuticals industry,0.326933
metabolic disorders,-0.541427
detailed information,0.457727
therapy areas,0.545344
infectious disease,-0.445626
nose throat disorders,-0.568276
licensing deals,0.611158
licensing agreements,0.30602
M&A Deals,0.266932
venture financing deals,0.470262
trend analysis,0.483094
partnerships,0.358706
milestone payments,0.54513
deal performing segments,0.252151
time sensitive manner,0.715638
hormonal disorders,-0.636012
report,0.381352
latest industry data,0.457934
financial advisory firms,0.326933
key financial advisors,0.352227
essential source,0.483094
pharmaceutical industry,0.45357
market research solution,0.782687
global arena,0.373618
clinical development stages,0.248767
deals,0.482079
detailed comparative data,0.422083
different payment modes,0.644932
deal trends,-0.393876
health segments,0.423157
equity/debt offerings,0.238161
sex hormones,-0.454251
decision making capability,0.715638
Q4,-0.247144
dental disorders,-0.61151
hematological disorders,-0.662641
financial advisors,0.352227
niche therapy areas,0.581029
market trends,0.373618
venture capital financing,0.509659
